Der var enighed om, at langtidsvirkningen af venlafaxin som depottablet var underbygget af de fremlagte data til GAD- indikationen.
15 Generalised Anxiety Disorder (GAD): it was agreed that the long term efficacy of prolonged-release venlafaxine in the GAD indication was supported by the data provided.